
New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes: Bridging Clinical Innovation and Practice
May 22, 2024 | 7:00 PM ET

Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise
May 23, 2024 | 7:00 PM ET

